Your Notifications
All done, no notifications

What is Triple-Negative Breast Cancer (TNBC)?

About 10–15% of all instances of breast cancer are triple-negative breast cancer (TNBC), an uncommon yet aggressive and rapidly spreading cancer that lacks three typical receptors found in most breast cancers: estrogen receptors (ER), progesterone receptors (PR), and the HER2 protein. Globally, TNBC is the most common cause of death for females and the most aggressive type of metastatic cancer.

What is the Importance of Timely Treatment?

Timely treatment of Triple-negative breast Cancer is crucial for many possible reasons :

  • Preventing Spread- Early detection can stop TNBC from spreading to other body sites, including lymph nodes, particularly those in the underarms. Due to its aggressive nature, Early efforts to limit its spread boost the chances of a successful course of treatment.
  • Improving Survival- Women with TNBC tend to have a worse outcome than women with other common types of breast cancer due to its aggressiveness; the survival rates for TNBC are generally not as high as they are for different types of breast cancer. For better outcomes, early intervention can significantly increase long-term survival.
  • Reducing Complications- Early treatment reduces the risk of complications, such as spreading complications to other organs through lymph nodes or the bloodstream, also called metastasis, and the need for more aggressive treatments.
  • Preserving Quality of Life - Less invasive techniques and improving surgical outcomes are frequently used in early treatment, enhancing quality of life and speeding up recovery.
  • Psychological Benefits- Early diagnosis and treatment can reduce stress and anxiety linked with the uncertainty of untreated cancer.

What are the Common Symptoms of Triple-Negative Breast Cancer (TNBC)?

  • Any inexplicable change in the breast's size or form, such as swelling or shrinking (mainly if it only affects one side).
  • Dimpling or puckering in the breast's skin gives it an orange-peel appearance.
  • Breast or nipple pain
  • Nipple retraction
  • Nipple discharge
  • Swollen lymph nodes
  • Scaly, red, or swollen skin on the breast, nipple, or areola

Causes and Risk Factors of Triple-Negative Breast Cancer (TNBC)

Traditional risk factors for all types of breast cancer, including lifestyle and environmental factors, also apply to triple-negative breast cancer. The exact causes of TNBC are not fully recognised, but several factors are involved in its development:

  • Genetic Mutations: Mutations in BRCA1 and BRCA2 genes are primarily associated with TNBC.
  • Hormonal Factors: TNBC does not react to hormonal treatments because it lacks HER2, progesterone, and estrogen receptors.

Risk Factors

  • It tends to occur in younger women under age 40.
  • Women are at higher risk of TNBC than men, and black women appear to develop TNBC more than white women.
  • Genetics also increases the risk factor of TNBC if there is any family history of breast cancer, especially with BRCA1 or BRCA2 mutations.
  • TNBC is more common in Premenopausal women.
  • Obesity
  • Alcohol Consumption

Connect with our advisor for a PRIORITY response

Latest Research and Technologies in the Treatment of Triple-Negative Breast Cancer (TNBC) in Turkey

High-resolution imaging, genetic analysis, and individualized therapy regimens have helped Turkey make tremendous strides in the diagnosis and treatment of triple-negative breast cancer (TNBC). In clinical trials conducted at several Turkish oncology facilities, immunotherapy—specifically, pembrolizumab in combination with chemotherapy—has demonstrated encouraging outcomes. In order to provide patients with access to innovative therapies like antibody-drug conjugates and customized vaccinations, Turkish hospitals actively take part in international clinical trials.

Triple-Negative Breast Cancer (TNBC) Prevention Tips

Triple-negative breast cancer (TNBC) cannot be prevented, although there are lifestyle behaviours that can lower the risk. Here are some tips-

  • Maintain a balanced diet rich in fibres that include fruits, vegetables, whole grains, and lean proteins; certain foods are associated with reducing breast cancer risk, for example, broccoli, kale, plant active compounds like EGCG(green tea) and berberine consumption are associated with anticancer properties. Avoid alcohol consumption as it increases the risk of breast cancer in women.
  • Lifestyle modifications should be made by staying physically active to maintain a healthy weight. Being overweight or obese increases the risk of breast cancer in women.
  • Quit smoking
  • Visit your healthcare professionals for routine checkups and routine procedures like mammograms and breast examinations to detect any early abnormalities.
  • Limit Hormone replacement therapies and use them over a short period that too, under the medical guidance of healthcare professionals.
  • Recognise early breast cancer symptoms like severe nipple retraction and unusual inflammation like swelling, itching, and breast enlargement, and seek medical attention if needed.
  • Genetic counselling to assess the risk factors and preventive measures are required if there is any family history of breast cancer.

Treatment options for Triple-Negative Breast Cancer (TNBC)

Medical professionals and researchers are still looking at novel approaches to treating TNBC. Recent clinical studies are evaluating novel drug combinations and new approaches to current therapies. The following are a few current treatments:

Chemotherapy: Healthcare providers might combine chemotherapy and surgery to treat early-stage triple-negative breast cancer. Which might be given before the surgery to shrink the tumour size and also post-surgery to kill any remaining cancer cells and reduce the risk of recurrence.


Cost Start From USD 7420 - USD 30000Explore Options

Immunotherapy: Healthcare Providers may combine immunotherapy and chemotherapy to shrink the size of tumors before surgery.


Cost Start From USD 7420 - USD 42500Explore Options

Targeted Therapy: Treatments that target malignant cells may be combined with immunotherapy and chemotherapy. For instance, doctors might employ PARP inhibitors as a targeted therapy. Poly ADP ribose polymerase, or PARP for short, is a cellular enzyme that fixes damage to DNA.


Cost Start From USD 7500 - USD 12000Explore Options

Lumpectomy: It is the removal of a small margin of the surrounding tissue of the breast. It is also known as breast-conserving surgery. A lumpectomy may be followed by radiation treatments to treat any residual cancer cells.

Mastectomy: It is the removal of the entire breast. Mastectomy is a treatment for patients with multiple, very aggressive, or large invasive ductal tumours in most advanced cases.


Cost Start From USD 6000 - USD 75000Explore Options

Clinical Evaluation

  • Medical History: Assemble information about symptoms, medical history and risk factors involved.
  • Physical Examination: Check for indications of breast swelling, redness and changes in shape, size and colour of the breast skin.

Imaging Studies

  • Mammogram
  • Magnetic Resonance Imaging (MRI)
  • Ultrasound

Biopsy

  • Core needle Biopsy
  • Surgical Biopsy
  • Fine Needle Aspiration

Laboratory Tests

  • Immunohistochemistry (IHC)- This test detects the presence of estrogen receptors (ER), progesterone receptors (PR), and HER2 protein to validate the diagnosis of TNBC.
  • Genetic Testing- Finds genetic alterations linked to an increased risk of TNBC, including those in the BRCA1 and BRCA2 genes.

MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services to support patients through Teleconsulations and online therapy sessions.

  • Physical Rehab: Encouraging light-moderate exercises like Scar tissue mobilisation therapy to improve patients' strength and mobility if surgery was involved. Similarly, Range of motion exercises can help prevent deep vein thrombosis (DVT). Lymphatic drainage exercises promote lymphatic fluid flow away from the affected area. Our graded exercise programs allow patients to lead a dignified lifestyle.
  • Lifestyle changes and modification: Nutrition is supported by dietary changes that include high-fiber foods and supplements, and wellbeing is enhanced by lifestyle modifications including abstaining from alcohol and controlling stress. Meditation and yoga improve mental health and lower stress.
  • Monitoring and follow-up: Schedule regular follow-up appointments with the oncologist to address complications, monitor recovery, and detect any signs of recurrence.

Depending on the circumstances, your doctor might recommend medication to help manage your symptoms and complement the course of treatment.

Instantly Connect with our Specialists

Doctor 1
Doctor 2
Doctor 3
Doctor 4
Doctor 5
Doctor 6
Doctor 7
Doctor 8

Hospitals for Triple-Negative Breast Cancer (TNBC) in Turkey

Medicana Camlica Hospital: Top Doctors, and Reviews
Medicana Camlica Hospital

Istanbul, Turkey

Medicana Camlica Hospital located in Istanbul, Turkey is accredited by JCI. Also listed below are some of the most prominent infrastructural details:

  • 150 bedded Hospital
  • Specialty-based clinics
  • Fully-equipped patient rooms
Hisar Intercontinental Hospital: Top Doctors, and Reviews
Hisar Intercontinental Hospital

Istanbul, Turkey

Architecture of the Hospital designed as per the comfort of patients-

  • Consisting of 8 floors, 212 bed capacity
  • 75m2 suite rooms
  • 35 thousand m2 closed area
  • 7 operating rooms
  • 53 polyclinics
  • 54 Departments
  • Hotel-like patient rooms
  • Intensive care units consisting of 33 beds
  • Hyperbaric Oxygen Center inside the hospital
  • PYXIS computerized medicine system working with fingerprint
  • Social waiting areas
  • Indoor and Outdoor Cafeterias & Restaurants
Acibadem Kadikoy Hospital: Top Doctors, and Reviews
Acibadem Kadikoy Hospital

Istanbul, Turkey

Acibadem Kadikoy Hospital located in Istanbul, Turkey is accredited by JCI. Also listed below are some of the most prominent infrastructural details:

  • The number of beds in the hospital are 138 and Intensive Care beds are 23.
  • There are as many as 6.500 access points for a building control system.
  • There are 10 Operating theatres and more than 500 employees.
  • There are specific healthcare facilities in Acibadem Kadikoy Hospital, Istanbul, Turkey which have been established per integrated healthcare outreach such as Breast Health Center, Check-up Center, and Diabetes Clinic etc.
  • The hospital has the very best of Medical Technologies such as Flast CT, da Vinci robot, Magnetom Area MRI, Greenlight, Ortophos XG 3D and Full Body MRI, 4-Dimensional Breast Ultrasound, 3-Dimensional Tomosynthesis Digital Mammography.

Our Services to better your experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Why Choose Turkey for Triple-Negative Breast Cancer (TNBC) Treatment?

  • Advanced Medical Centers: Turkey's modern hospitals and medical facilities have the newest technologies to spot and treat TNBC. Many hospitals have dedicated departments for breast cancer care and surgery for TNBC with experienced and skilled oncology surgeons.
  • Cost-Effective Treatment: Compared to Western countries, excellent care is offered cheaply without compromising the quality.
  • Comprehensive Care: Turkey hospitals follow a holistic approach to treatment, including pre-operative evaluation, surgery, post-operative evaluation, dietary support, psychological counselling, and medical and surgical intervention.
  • Advanced Diagnostic tools: Advanced diagnostic treatment like mastectomy is available in Turkish hospitals to ensure precise diagnosis and treatment planning.

Frequently Asked Questions

A worse prognosis is frequently associated with triple-negative breast cancer (TNBC), a more aggressive kind of the disease that develops and spreads quickly. Treatment options are limited because TNBC cannot be treated with hormonal or targeted therapy due to its lack of estrogen, progesterone, and HER2 receptors. Because of its aggressive character, early detection and prompt treatments are crucial for better results.

Within weeks to months, triple-negative breast cancer (TNBC) frequently grows and spreads. Because of its aggressive nature, early detection and timely treatment are essential.

The adverse effects vary from therapy to treatment. Furthermore, how each person responds to these side effects may vary. Inquire about the adverse impact of a particular treatment from your doctor. They will outline how they will assist you in managing them and what you may do to benefit yourself.

Recent advancements in the discovery of novel therapies, including immunotherapy and PARP inhibitors, have improved the prognosis for TNBC. Medical researchers are using existing treatments in novel ways. The prognosis for triple-negative breast cancer is better the earlier medical professionals identify it, as is the case with most cancers.

The stage at which triple-negative breast cancer (TNBC) is diagnosed affects the survival rate. About 91% of people with localised TNBC, 66% of people with regional TNBC, and 12% of people with distant TNBC will survive for five years. All stages together have a 5-year survival rate of about 77%2. Improving outcomes requires early detection and timely treatment.

Yes, triple-negative breast cancer (TNBC) can cause irreparable harm, particularly if the disease is not identified and treated quickly. TNBC is an aggressive type of breast cancer that can cause more serious and reversible harm by swiftly spreading to lymph nodes and other body parts. Early detection and timely treatment are essential to avoid irreparable harm and increase the likelihood of positive results.

One can go home 1-2 days after the Lumpectomy surgery, and it takes 5-10 days to recover and fully regain normal activities. Similarly, 1-2 days of hospital stay in Mastectomy and 3-4 weeks of full recovery to normal activities.

Yes, Turkey provides cutting-edge diagnostic techniques for Triple-Negative Breast Cancer (TNBC), such as molecular profiling, MRI, PET-CT, and digital mammography. Top hospitals offer modern imaging and biopsy methods for accurate diagnosis.

Turkey is a cost-effective choice for those seeking treatment because it provides top-notch medical care at affordable costs when compared to several Western nations.

Yes, Turkey's healthcare system accepts patients from abroad and provides excellent TNBC treatments at many clinics and hospitals.

Yes, many Turkish hospitals offer in-person and online consultations to foreign patients who want a second opinion.

Yes, immunotherapy is frequently used in conjunction with chemotherapy to improve the prognosis of patients with TNBC.